HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Topical Progesterone Cream Yields Prescription-Level Exposure - Study

This article was originally published in The Rose Sheet

Executive Summary

Topical progesterone cream results in the same level of exposure to progesterone as prescription oral micronized capsules, according to a small study presented by Anne Hermann, MD, at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics in Miami March 25
Advertisement

Related Content

Hormone-Containing Cosmetics Rule Should Be Pursued – Advocacy Groups
Hormone-Containing Cosmetics Rule Should Be Pursued – Advocacy Groups
Advertisement
UsernamePublicRestriction

Register

RS012010

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel